Illinois Municipal Retirement Fund Has $26.41 Million Position in CME Group Inc. $CME

Illinois Municipal Retirement Fund grew its holdings in CME Group Inc. (NASDAQ:CME) by 65.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 96,714 shares of the financial services provider’s stock after purchasing an additional 38,147 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in CME Group were worth $26,411,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. West Family Investments Inc. boosted its stake in CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares in the last quarter. Asset Dedication LLC boosted its stake in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC boosted its stake in CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group boosted its stake in CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 37 shares in the last quarter. Finally, 1248 Management LLC boosted its stake in CME Group by 26.8% in the third quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 38 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, a regulated cash-settled product tied to a benchmark of major cryptocurrencies including Bitcoin, Solana, XRP and others. The new offering could attract more trading volume from investors seeking broad crypto exposure and hedging tools. Article Title
• Positive Sentiment: CME Group and Morningstar announced an exclusive multi-year licensing agreement to launch derivatives based on Morningstar equity index benchmarks, opening a new product line tied to indexes that underpin more than $3 trillion in linked assets. Article Title
• Positive Sentiment: Shareholders maintained CME’s Class B governance structure and rejected a bid to end those director election rights, removing a potential governance overhang and preserving the company’s current control framework. Article Title
• Neutral Sentiment: CME also announced its second-quarter 2026 earnings release date for July 22, which is mainly a scheduling update but keeps attention on upcoming results. Article Title
• Neutral Sentiment: Reports about short interest and options activity suggest traders are watching CME closely, but those items do not yet point to a clear fundamental catalyst. Article Title

Analyst Ratings Changes

A number of research firms have recently weighed in on CME. Deutsche Bank Aktiengesellschaft dropped their target price on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. The Goldman Sachs Group dropped their target price on CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a research report on Thursday, April 23rd. Raymond James Financial boosted their target price on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research report on Monday, April 6th. Argus restated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Finally, Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, April 26th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $305.29.

CME Group Trading Up 3.1%

CME stock opened at $263.80 on Thursday. The company has a market cap of $95.59 billion, a P/E ratio of 22.51, a PEG ratio of 2.86 and a beta of 0.21. CME Group Inc. has a twelve month low of $244.56 and a twelve month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a fifty day moving average of $286.00 and a 200-day moving average of $288.28.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.80 earnings per share. As a group, equities research analysts expect that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio is currently 44.37%.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the sale, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. This represents a 31.39% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 44,044 shares of company stock worth $13,297,507. 0.30% of the stock is owned by insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.